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 An original method to extract and detect barbiturates, specifically secobarbital, in 
hair by enzyme-linked immunosorbent assay (ELISA), has been developed. Drug-free 
hair specimens were fortified with an exaggerated amount of secobarbital to produce a 
homogeneous, true positive sample to be utilized to test the drug extraction efficiency 
from hair. Drug extraction using hair extraction buffer (HEB) from Immunalysis was 
compared to a base digestion using 1M NaOH. After LCMS/MS analysis, HEB 
extraction was deemed a successful method for extracting barbiturates from hair. Using 
this method, the Barbiturates Direct ELISA Kit from Immunalysis was evaluated for its 
potential use in the detection of barbiturates in hair specimens. After thorough analysis, it 
























1. Barbiturates Background 
The worldwide rise in prescription drug misuse has not gone unnoticed. Over the 
last 15 years, misuse has been reflected in increased emergency room visits, treatments 
for addiction, and deaths due to overdose (NIDA, 2016). Overdose deaths alone have 
increased from almost 10,000 in 2001 to more than twice that amount at 25,000 in 2014 
(NIDA, 2016). There are three main culprits of misused prescription drugs, one of which 
are central nervous system depressants. This category of drugs includes substances that 
can slow brain activity (i.e. tranquilizers, sedatives, and hypnotics). An example of which 
are barbiturates. In 2011, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) reported that approximately 18,000 emergency calls 
involving the use of non-prescribed barbiturates took place in the United States 
(SAMHSA, 2013). Additionally, a study done in the UK from 1983-1999 found that for 
every million barbiturate prescriptions, 146.2 lead to fatal toxicities (Buckley, & 
McManus, 2004). Because of its higher risk in overdose fatalities, barbiturates have 
mostly been replaced by benzodiazepines, but they are still prescribed today.  
Barbiturates were introduced into medicine in 1903 after the discovery of its 
sedative-hypnotic action; dominating the market for the first half of the 20th century. 
Today, there are numerous variants available, all of which are derivatives of barbituric 
acid – typically differing at the C5 position in structure. These modifications affect the 
compound’s lipid solubility and, thus, duration of activity (Levine, 2013). For example, 
secobarbital contains an allyl and 1-methylbutyl group at the C5 position which makes it 
more lipid soluble and potent but, also, short acting. As stated above, this drug class is a 
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central nervous system (CNS) depressant that has been primarily prescribed as sedative 
hypnotics, anticonvulsants, and for migraine therapy (Levine, 2013). Barbiturates are 
most commonly administered orally, but have been known to be given intravenously or 
intramuscularly. They are rapidly absorbed and distribution occurs throughout the major 
tissues of the body (Silberstein, & McCrory, 2001). Depending on the duration of action, 
barbiturates are either almost completely metabolized (short-acting) by the liver or 
remain mostly unchanged (long-acting) (Silberstein, & McCrory, 2001). They 
preferentially suppress polysynaptic neuronal responses primarily by binding to a 
chloride ion channel, γ-aminobutyric acid (GABA) A receptor. This, in turn, activates the 
receptor, prolonging the opening of the channel and allowing for an influx of chloride 
ions (Silberstein, & McCrory, 2001). Although benzodiazepines also interact with the 
GABAA receptor, they potentiate different reactions. Barbiturates cause the receptor to 
remain open for longer, whereas, benzodiazepines increase the affinity of GABA for the 
receptor (Bianchi, Botzolakis, Lagrange, & Macdonanld, 2009). Because of this, the 
therapeutic index for barbiturates is low – increasing the likelihood of intoxication and 
overdose. Intoxication symptoms include: sluggishness, difficulty thinking, poor memory, 
slowed speech and comprehension, impaired judgement, and decreased attention span 
(Silberstein, & McCrory, 2001). Although barbiturates can produce tolerance, and result 
in dependence and addiction, some are still administered today and should be closely 




Secobarbital is a short-acting barbiturate with a half-life of 22-29 hours 
(Levine, 2013). It is typically used to treat insomnia, or as a sedative before 
surgery. 
1.2 Butalbital 
Butalbital is an intermediate-acting derivative of barbituric acid. Commonly 
compounded with aspirin, acetaminophen, and/or caffeine, they are widely 
used for the treatment of migraines and tension-type headaches (Silberstein, & 
McCrory, 2001). 36% of patients taking prescription medicine for their 
headaches, take butalbital-containing analgesic combinations (Ferrari, 
Tifaferri, Palazzoli, Verri, Vandelli, Marchesi, Ciccarese, & Licata, 2015). 
1.3 Phenobarbital 
Phenobarbital is a long-acting barbiturate with limited metabolism and an 
elimination half-life of 2-5 days. It is one of the more commonly prescribed 
barbiturates today for its use in the treatment of epileptic seizures (Levine, 
Roveri, Paranhos, & Yonamine, 2016). 
 
2. Hair Matrix 
 In recent years, analysis of the hair matrix has gained increasing importance in the 
determination of substances of abuse. With hair having the longest window of drug 
detection, as compared to the other more classic biological specimens (urine, oral fluid, 
and serum, in that order respectively), it has gained popularity of use in forensic cases 
and clinical toxicology. Typically, drug detection in hair is from weeks to months, where 
as in urine it is from hours to days and in blood, minutes to hours (Levine, 2013). This 
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allows for diagnostic information regarding the identity and concentration of drug(s) to 
be obtained over an extended period of time. Other advantages to using hair as a matrix 
include: its non-invasive collection; and its long and easy storage. With barbiturate 
analysis having been previously demonstrated in urine, serum, and oral fluid, this study 
established it for hair analysis for use in patient drug monitoring and/or forensic case 
work.  
 Hair is a non-homogeneous fiber; it is solid and durable. It consists of keratinized 
cells that form three concentric structures –the cuticle, cortex, and medulla (Figure 1) 
(Pragst, & Balikova, 2006).  
 Figure 1. 
   
Figure 1. Structure and constituents of the human hair shaft. 
 
Each fiber originates from the hair follicle, which resides 3-5 mm below the scalp-dermal 
layer and is nourished by a network of capillaries (Pragst, & Balikova, 2006). The cuticle 
consists of a thin layer of cells that overlap in a shingle-like fashion and make up the 
outside of the hair shaft (Levine, 2013). Beneath the cuticle contains the cortex which 
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consists of tightly packed, keratin-filled, microfibrils that make up the cell membrane 
complex (Levine, 2013). This part of the hair is the primary diffusion point for 
incorporation and diffusion of drugs, with lipophilic drugs being preferentially deposited 
(Pragst, & Balikova, 2006). Lastly, the most inner part of the hair structure is the medulla. 
Here is where ingested drugs are primarily deposited (Levine, 2013). The life cycle of 
human hair consists of three main phases – the anagen phase, catagen phase, and telogen 
phase (Levine, 2013). The anagen phase is also known as the growth phase. During this 
phase, the hair grows at a rate of about 0.44mm per day (0.38-0.48mm) for men and 
0.45mm per day (0.4-0.55mm) for women (Nakahara, 1999). At this rate, drugs within 
the hair emerge above the surface about 5-7 days after ingestion (Levine, 2013). The 
catagen phase, or transition phase, is when the root end of the hair becomes keratinized 
and begins to separate from the bulb (Levine, 2013). After about 4-6weeks, the hair 
enters the telogen phase, or resting phase, in which the hair shaft stops growing 
completely and can be easily pulled out (Nakahara, 1999).  
There are several mechanisms in which drugs can be incorporated into hair. One 
of which is through passive diffusion from the blood capillaries into the matrix cells of 
the growing hair (Levine, 2013). Another, is via sweat or sebum secretions (Pragst, & 
Balikova, 2006). In addition, substances such as smoke and powders can be deposited 
from the external environment, making the hair washing step prior to extraction critical 
(Nakahara, 1999). Experimental data has also suggested that delayed incorporation can 
occur from deep skin compartments during hair shaft formation (Pragst, & Balikova, 
2006).  
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The mechanism that will predominate is strongly influenced by the structural and 
chemical properties of the drug, as well as, the physical and physiological characteristics 
of the individual. An example of this is an individual’s hair pigmentation. It has been 
shown that pigmented hair had about a 10-fold higher concentration of basic drugs than 
that of non-pigmented hair, despite having the same drug concentration in blood (Rothe, 
Pragst, Thor, & Hunger, 1997). Additionally, it has been demonstrated that melanin, the 
compound responsible for hair pigmentation, has a stronger affinity for basic drugs 
(Claffey, Stout, & Ruth, 2001).  
For analysis, a sample of hair is taken from the back of the donor’s scalp in a 
cosmetically consealable area. This lock is about 1 inch wide by 1-2 strands deep and cut 
close to the scalp (Levine, 2013). It is wrapped in foil with the cut, root-end protruding 
and stored in an envelope in a cool dry place for as long as 5 years. Generally, 
approximately 4cm (or 1½ inches) of collected hair is cut from the root end for analysis. 
This length of hair reflects approximately 90 days (Levine, 2013). The sample of hair is 
then typically either cut into smaller segments, or pulverized in a ball mill, allowing for 
greater surface area to optimize the extraction process. Prior to the extraction process, the 
hair is weighed into aliquots (typically ranging from 10-50mg, depending on the assay) 
and then washed. Because hair is exposed to the outside environment, it may become 
contaminated with drugs via vapor or direct contact and, thus, an efficient wash 
procedure is necessary. The challenge in any wash procedure is to remove as much drug 
present on the surface of the hair while keeping the internalized drug within the hair for 
analysis. There are many wash techniques implemented today, but in general, it involves 
an incubation with an organic solvent (such as dichloromethane, isopropanol, or 
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methanol), followed by an additional one or two washes with an aqueous solvent (such as 
sodium phosphate buffer) (Levine, 2013). The use of an organic solvent removes any 
external contaminants residing on the exterior of the hair, while the aqueous solution 
causes the hair to swell – both allowing for the removal of any drugs that may have 
diffused from the exterior to the cortex of the hair. Similar to the wash procedure, there is 
no designated method for the extraction of drugs from hair. Typical procedures incubate 
the hair in an organic solvent (most commonly methanol) for extended periods of time, 
ranging from 5-18 hours (Pragst, & Balikova, 2006). However, studies have shown that 
basic drugs are well extracted using either aqueous acids or phosphate buffer (Moeller, 
Fey, & Wennig, 1993; Kintz, & Mangin, 1995). Whereas, compounds that are stable 
under alkaline conditions, typically extract well using a 1M NaOH digestion for much 
shorter periods of time. In this study, a commercially available hair extraction buffer 
(HEB) was utilized. To determine that the HEB was the optimal extraction technique for 
barbiturates, it was tested against 1M NaOH dissolution using in-house prepared fortified 
hair samples. Although some laboratories use authentic hair, fortified hair ensures 
homogeneity and has been used in proficiency testing programs since 1990 (Lee, Park, 
Han, Choe, Lim, & Chung, 2008). Because it has been shown that DMSO is a useful 
penetrating carrier for absorption enhancement of the compound of interest into the hair, 
a 50% solution of DMSO ± 0.02M HCl was utilized in the fortification process (Welch, 




The first hair analyses for drugs were performed by radioimmunoassay (RIA) 
(Pragst, & Balikova, 2006). Today there are more options readily available –like the 
enzyme-linked immunosorbent assay (ELISA), for example. The ELISA is an excellent 
screening technique for hair drug testing due to its sensitivity and ability to detect low 
levels. However, these assays are not typically validated for use in hair and thus must be 
before use. The principle design behind an enzyme immuoassay is the antigen-antibody 
interaction. A host organism is injected with a drug/compound bound to a carrier protein 
to induce an immune response (Levine, 2013). As a result, antibodies against the target 
analyte are produced and subsequently collected for use in commercial screening kits. 
Because the antibodies produced have different epitopes towards the target, cross-
reactivity between similarly structured compounds occurs. The antibodies are then fixed 
to a 96-well plate, where sample and enzyme-conjugated target drug compete for 
antibody binding sites (Levine, 2013). The enzyme conjugate is typically horseradish 
peroxidase (HRP). Following the addition of a substrate, 3,3’,5,5’-tetramethylbenzidine 
(TMB), any bound HRP-conjugated target drug will oxidize the chromogenic substrate 
into a blue colored product. A Stop Solution containing a dilute HCl solution is then 
added to quench the reaction and, ultimately, changing the color reaction from blue to 
yellow. In the event that a sample is positive, very little HRP-conjugated drug will bind 
causing a slight color change. Whereas, a negative sample will produce a greater color 
change. The absorbance is measured spectrophotometrically. In this study, the 
Barbiturate Direct ELISA Kit from Immunalysis was validated for the presumptive 




A liquid chromatography tandem mass spectrometry system (LCMS/MS) is 
an instrument that allows for the separation, detection, and identification of compounds 
(Skoog, Holler, & Crouch, 2007). Liquid chromatography separates the sample 
components while bringing them to the mass spectrometer, where the compounds are 
ionized, detected, and identified (Skoog et al., 2007). The use of a calibration curve made 
up of known concentrations of the target analyte allows for its quantification. A 
deuterated form of the analyte is used to control for extraction, and LCMS/MS injection 

















1. Chemicals and Reagents: 
Secobarbital and secobarbital-d5 were purchased from Cerilliant (Round Rock, 
TX). The Barbiturates Direct ELISA kit, hair extraction buffer (HEB), bovine serum 
albumin (BSA), and neutralizing buffer (NEB) were obtained from Immunalysis 
Corporation (Pomona, CA). All HPLC grade solvents and ACS grade chemicals were 
purchased from VWR (Radnor, PA). All consumables were purchased from VWR 
(Radnor, PA) unless otherwise noted. Trace-B mixed-mode solid phase extraction (SPE) 
columns, autosampler vials, and autosampler snap caps were purchased from SPEware 
Corporation (Baldwin Park, CA).  
 
2. Apparatus: 
The Tecan-fre (used to pipette all calibrators, controls, and samples into the 
microplate wells), the Columbus Plus plate washer, and the Sunrise® Basic Tecan plate 
reader were all purchased from Tecan (San Jose, CA). Magellan software was used to 
analyze the OD readings. The CEREX ALD III 48 used to dispense solvents and 
solutions during the solid phase extraction, was purchased from SPEware (Baldwin Park, 
CA). All confirmational analyses were performed using a liquid chromatography/tandem 
mass spectroscopy system (LCMS/MS). The LC system used was an Agilent 1290 
Infinity Series, coupled to an Agilent 6460 triple quadropole tandem mass analyzer 
equipped with a jet stream electrospray ionization source. The analytical columns used 
were Zorbax® Eclipse Plus C18 columns with a 2.1 mm diameter, 50 mm length, and 1.8 
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µm particle size (Agilent Technologies, Santa Clara, CA). The mobile phases used were 
0.2% acetic acid and acetonitrile. 
 
3. Samples: 
Drug free hair was voluntarily donated from the author and stored in a sealed bag 




















1. Sample Preparation: 
The hair was cut into 1-2 cm sections and 10 mg aliquots were placed into 
13x100mm glass tubes. Hair samples were then washed with dichloromethane, isopropyl 
alcohol, and methanol to remove external contamination. 1 mL of each solvent was added, 
vortexed for 5 minutes, decanted and evaporated with a gentle stream of nitrogen at 65°C.  
 
2. Calibration Curve for Screen: 
Eight aliquots of 10 mg of washed negative hair was prepared. To this, different 
concentrations of secobarbital was added. Concentrations of 0 pg/mg (negative control), 
250 pg/mg (low positive control), 500 pg/mg (calibrator cutoff), and 1000 pg/mg (high 
positive control) of secobarbital were spiked in duplicate.  
 
3. Drug Extraction from Hair: 
Calibrators, quality controls, and unknown samples were subjected to 550 μL of 
HEB. The samples were then incubated at 75°C for 2 hours, followed by neutralization 
using 50 μL of NEB. After centrifugation at 4,200 rpm for 10 min, 200 μL of supernatant 
was transferred to another tube and diluted with 400 μL of BSA and vortexed. 
 
4.  ELISA: 
The diluted extracts were added to the microtiter plate at 10 μL per sample. 
Subsequently, 100 μL of the enzyme conjugate was added and the plate was incubated at 
room temperature for one hour. Unbound antigen was removed by washing the wells with 
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350 μL of dH2O (6 cycles). After the plate was pat dry, 100 μL of TMB solution was 
added and allowed to incubate for 30 minutes at room temperature. Immediately after this, 
100 μL of Stop Solution was added to the wells and the plate was read at 450 nm using a 
spectrophotometer  (using 620 nm as a reference wavelength) and analyzed using the 
Magellan software. 
 
5.  Intraday Study: 
Negative, low, calibrator, and high controls (n=8 per calibrator/control) were 
prepared  and analyzed on a single day along side the calibration curve. Intraday study 
results were averaged and then compared to the results of the calibration curve to 
determine intraday precision and accuracy using the following equations:  
 Relative Standard Deviation (RSD) = SD/xi * 100 
 Mean Relative Error (MRE) = ((xi – x)/x) * 100 
where SD is the standard deviation, xi is the mean of the observed concentration, and x is 
the true concentration. 
 
6.  Interday Study: 
Negative, low, calibrator, and high controls (n=5 per calibrator/control per day) 
were prepared and analyzed along side the calibration curve each day over the course of 8 
days. The results of the samples were then compared to that of the calibration curve to 
determine interday precision, accuracy and assay reproducibility. Used same equations 
from intraday study. 
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7.  Carryover Study: 
An aliquot of washed negative hair was spiked with secobarbital at four times the 
concentration of the high control to prepare a carryover sample. The calibration curve and 
sample were analyzed and carryover was determined by comparing the results of the 
negative controls, which were aliquotted before and after the carryover sample. 
 
8.  Fortified Hair Preparation: 
Negative hair was soaked in a high concentration of secobarbital for several days 
to mimic that of authentic, true positive samples. To this end, 1g of negative hair was cut, 
washed and then added to a bottle containing one of two solutions. One solution was 
made up of deionized water (dH2O) and dimethyl sulfoxide (DMSO) at a 1:1 ratio for a 
total of 17mL (Welch et al., 1993).The second solution contained a 1:1 mixture of dH20 
and 0.02M HCl in DMSO for a total of 17mL (Welch et al., 2003; Lee et al., 2008). 
Secobarbital was spiked into these solutions at 100 times the cutoff value of 500pg/mg. 
Everyday the solutions were sonicated for 1 hour and every 3 days a portion of the hair 
was removed for analysis. The amount of hair removed from the solution was estimated 
to be 30mg of hair so as to analyze the sample in triplicate. The aliquot of hair was 
washed using the same protocol as mentioned above except 3mL of each solvent was 
used. Additionally, the last wash was saved to be screened alongside the fortified hair 
sample. Once the sample was dried down at 65°C, it was weighed and three aliquots of 
10mg of hair was prepared. To each, 550μL of HEB was added and incubated for 2 hours 
at 75°C. Following incubation, the samples were neutralized, centrifuged, and diluted 
according to the same procedure stated above. The previously saved wash was prepared 
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similarly after having been divided into three 1mL aliquots and evaporated to dryness 
using a gentle stream of nitrogen. 10μL of each sample (three aliquots of extracted hair 
and three aliquots of last wash per each condition) was added to the Barbiturate Direct 
ELISA Kit plate, along with a calibrator and QCs, and the same ELISA screening 
procedure was carried out as mentioned above. This process was repeated until the hair 
samples screened positive while the last wash screened negative. 
 
9.  Drug Extraction Efficiency Study: 
Secobarbital-fortified hair was used to compare the extraction efficiency of an 
aqueous extraction (using HEB) to that of a base digestion (using 1M NaOH). Given that 
a hair digestion dissolves the hair completely, it represents 100% extraction efficiency. 
To this end, 10 mg of fortified hair was subjected to either an aqueous extraction using 1 
mL of HEB and incubated for 2hr at 75°C or a base dissolution using 1 mL of 1M NaOH 
and incubated for 30min at 75°C, in triplicate. Secobarbital-d5 internal standard (100 μL) 
was also added at a concentration of 100 ng/mL. Following incubation, the samples were 
neutralized. The samples treated with the aqueous extraction were neutralized  using 1 
mL of 0.1M phosphate buffer (pH 6.0), whereas the samples digested with the base 
solution were neutralized using 300 μL of 20% acetic acid. Calibration curves were 
analyzed concurrently with each extraction procedure at concentrations of: 0, 25, 50, 100, 
250, 500, 1000, 2000, 5000, and 10000 pg/mg secobarbital. Additionally, quality control 
samples contained secobarbital at 100, 500, 1000, and 5000 pg/mg. All samples were 
processed using SPE extraction before analysis on the LCMS/MS. 
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10.   SPE Extraction: 
The extracted samples were cleaned up by using mixed mode cation-exchange 
solid phase extraction (SPE). These columns were used to allow for the simultaneous 
extraction of basic drugs, and the weakly acidic barbiturates through hydrophobic binding. 
The columns were conditioned with 1 mL each of methanol and dH2O. After 
centrifugation for 10 minutes at 4,200rpm, the sample supernatants were decanted into 
the conditioned SPE columns. Here, the samples were gently pushed through the column 
bed using a stream of nitrogen. The column beds were then washed with 2 mL of dH2O, 
followed by 2 mL of 0.1M acetic acid, and lastly by 2 mL of 25% methanol. Prior to 
elution using 1.5mL of a 80:18:2 solution of dichloromethane : isopropyl alcohol : 
ammonium hydroxide per sample, the column beds were dried for 14min at 45°C and 
with a stream of nitrogen at 50psi. Elutes were completely dried down at 40°C with the 
help of a gentle nitrogen stream. Samples were reconstituted in 100 μl of 0.1% formic 
acid.  
 
11. LCMS/MS Parameters: 
Secobarbital was analyzed using 0.2% acetic acid in water (mobile phase A) and 
acetonitrile (mobile phase B). The following gradient was utilized at a flow rate of 
0.5mL/min: 








Mass spectral analysis was performed using multiple reaction monitoring (MRM) 
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IV. RESULTS:  
1. Intraday Study and Limit of Detection (LOD) 
Eight aliquots of each of the following different concentrations of secobarbital 
was analyzed for the intraday study: 0pg/mg (Negative), 250pg/mg (Low QC), 500pg/mg 
(Calibrator), 1000pg/mg (High QC). Figure 2A is a plot of these calibration 
concentrations normalized to the negative control using the following equation: 
B/B0 × 100 
where B is the absorbance value of the bound calibrator and B0 is the absorbance value of 
the blank calibrator (Miller, Wylie, & Oliver, 2006). As can be seen from Figure 2A, the 
curve is linear with an R² value of 0.986. Figure 2B contains the cumulative data of the 
eight replicates for each of the concentrations. The relative standard deviation (RSD) and 
the mean relative error (MRE) were well within the acceptable range of 20%. 
The theoretical limit of detection was determined to be approximately 90 pg/mg 
using the data from Figure 2 and the following equation: 
LOD  = A0 – (3 × SDneg) 
where A0 is the mean absorbance value for the 8 negative samples, and SD is the standard 








Figure 2 – Intraday results  
 
 Figure 2. (A) ELISA dose response curve for secobarbital after intraday study. (B) 
The average absorbance obtained from all eight replicates for each concentration 












2. Interday Study 
For the next eight days the same procedure was followed, except the different 
concentrations were run in replicates of five instead of eight. The resultant data of the 
interday study can be seen in Figure 3. Figure 3A represents a plot of the averages of 
each of the points normalized to the negative control, using the same equation used for 
the intraday study – B/B0 × 100. The averages of all five readings obtained on all eight 
days for each of the calibrator and controls is represented in Figure 3B (n=40). As can be 
seen in Figure 3B, both the RSD and MRE were calculated to be well within the 
















Figure 3 – Interday Study 
 
Figure 3. (A) ELISA dose response curve for secobarbital after interday study. (B) 
The average absorbance obtained from the five replicates for all eight days for 













3. Carryover Study 
Using the automated liquid handler, Tecan-fre, a carryover study was performed. 
Here, the same negative sample was aliquotted onto the ELISA plate before and after an 
aliquot of a highly positive sample (4x the concentration of the high QC) was taken. As 
can be seen from Table 1 below, there was approximately a 3% difference between the 
absorbance value of the negative sample taken before and after the highly positive sample.  
 
Table 1 – Carryover Study 
 
Table 1. Absorbance values obtained from a negative sample before and after the 















4. Fortified Hair –Screening 
Following incubation with a high concentration of secobarbital for 6 days, the hair 
fortification process was complete. The extracted sample and last wash of the sample was 
analyzed by ELISA and the resultant absorbance values can be seen in Table 2B. In 
conjunction with Table 2A, it can be seen that the hair, whether soaked in a solution 
containing 50% DMSO or 50% 0.02M HCl in DMSO, screened positive for secobarbital 
–having average absorbance values of 1.27 and 1.37, respectively, which is lower than 
the cutoff absorbance of 1.84. Additionally, the last wash of either condition screened 
















Table 2 – Fortified Hair Screening Results 
 
Table 2. (A) ELISA calibration points of secobarbital used to screen for positive 
samples. (B) Absorbance values of the secobarbital-fortified hair samples using 











5. Fortified Hair –Confirmation 
Known concentrations of secobarbital were analyzed to create a calibration curve 
to determine the concentration of secobarbital extracted from the fortified hair samples 
(Figure 4A). The fortified hair samples were extracted using both HEB and 1M NaOH to 
determine the extraction efficiency of HEB and the resultant data can be seen in Figure 
4B. The fortified hair soaked in 50% DMSO (DMSO Fortified Hair) produced 3,243 
pg/mg of secobarbital when exposed to HEB, whereas the use of 1M NaOH produced 
2,847 pg/mg. In comparison, the hair fortified with 50% 0.02M HCl in DMSO (HCl 
Fortified Hair) resulted in a lower concentration of secorbarbital, producing 2,087 pg/mg 
of the analyte using HEB and 1,943 pg/mg using 1M NaOH. The %RSD for all is well 
below 20%. This demonstrates that, for either condition, HEB does, in fact, successfully 
extract secobarbital from fortified hair, resulting in quantities similar to that of the 












Figure 4 – Extraction Efficiency Results 
 
Figure 4. (A) LCMS/MS calibration curve of secobarbital concentrations ranging 
from 25-10,000 pg/mg. (B) The average concentration of secobarbital obtained 














 The validation procedure used for this study was designed to determine if this 
type of assay had the capabilities to perform barbiturate screening in hair. Furthermore, 
extensive investigations were conducted in order to ensure that the drug extraction was 
optimal and that the detection results were reliable and reproducible – a critical 
requirement if this assay is applied in situations of routine drug testing. Based on the data 
generated in this study, the heterozygous immunoassay can be imployed to differentiate 
between the cutoff concentration of secobarbital (500 pg/mg) and its respective low (250 
pg/mg) and high (1000 pg/mg) quality controls with using only 10 mg of hair. 
Additionally, this distinguishable separation between the concentration points is highly 
precise and reproducible, giving an RSD and MRE less than 20% over a course of 8 days 
with 5 repeats for each concentration.  Although the LOD concentration was derived 
theoretically, the resultant value was far less than that of the low control, indicating that 
the assay is sensitive enough to distinguish the low control from the LOD and subsequent 
background noise. It was also determined that, if an automated liquid handler is to be 
used, carryover from a high positive sample to a negative sample is highly improbable, 
deeming it an assay fit for high volume throughput.  
 There are a vast array of methods available in the literature on how to extract 
drugs from hair. Because the manufacturer of the ELISA kit used in this study also 
provides a hair extraction buffer, it was tested on its efficiency before continual use. 
Although both fortification solutions prepared for this study contained DMSO – a reagent 
documented to help in the fortifying process by way of carrying the drug into the hair – it 
was not known which solution (the one with 0.02M HCl or without) would work for this 
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drug class. After 6 days of incubation with an exaggerated amount of secobarbital in 
either DMSO solution, a positive result for the ELISA screen was obtained. Three 
separate aliquots of fortified hair from each condition resulted in an RSD value less than 
10% for both the extracted hair sample and its respective last wash – confidently 
solidifying its positivity was due to drug extraction and not removal of external 
contamination. The efficiency of the HEB extraction was then tested by comparing it to 
that of the 1M NaOH digestion. In concurence with the ELISA results, both fortification 
solutions produced hair samples positive for secobarbital. Interestingly, both conditions 
resulted in similar, if not, slightly greater quantities of secobarbital when using HEB than 
that extracted with 1M NaOH, demonstrating that HEB is an efficient buffer for the 















 Screening methods for the detection of various drugs in hair have been previously 
validated using immunoassays. The intent of this study was to validate a method to 
reliably extract and detect barbiturates, specifically secobarbital, in hair to accommodate 
the currently prominent need to monitor patients taking potentially abused, prescription 
drugs. The study demonstrates that picogram quantities of secobarbital can be extracted 
from 10 mg of hair using HEB, with both precision and reproducibility. Additionally, it 
was established that, in the event that an automated liquid handler is to be utilized, no 
carryover is seen when a negative sample was aliquotted following a very high positive 
sample. Ultimately, this method is a good resource for the presumptive detection of 
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